Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

T

TPST

Tempest Therapeutics Inc

0.9148

Aug 05 • 12:14 PM ET +0.0276 (3.11%)

Healthcare Biotechnology USA Nano NASD

Peers: ALLR CLRB JSPR LGVN MRKR NXTC PLUR PTN VTGN BCTX

| Held by: VXF VTI

Scroll to Statements

Index	-
Market Cap	14.62M
Enterprise Value	20.67M
Income	-43.10M
Sales	0.00M
Book/sh	0.06
Cash/sh	0.11
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	4
IPO	Nov 12, 2012

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	15.96
P/C	8.12
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	0.74
Current Ratio	0.74
Debt/Eq	9.57
LT Debt/Eq	8.07
Option/Short	No / Yes

EPS (ttm)	-6.21
EPS next Y	-
EPS next Q	-
EPS this Y	-
EPS next Y	-
EPS next 5Y	-
EPS past 3/5Y	46.00% 76.03%
Sales past 3/5Y	- -
EPS Y/Y TTM	65.65%
Sales Y/Y TTM	-
EPS Q/Q	19.80%
Sales Q/Q	-
Earnings	May 14 AMC
EPS/Sales Surpr.	-803.57% -

Insider Own	39.88%
Insider Trans	7.84%
Inst Own	3.03%
Inst Trans	-1.04%
ROA	-200.87%
ROE	-721.00%
ROIC	-579.51%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	-2.57%
SMA50	-19.40%
SMA200	-69.26%
Trades

Shs Outstand	14.34M
Shs Float	9.61M
Short Float	3.31%
Short Ratio	2.04
Short Interest	0.32M
52W High	12.23 -92.52%
52W Low	0.84 8.89%
Volatility	5.11% 7.75%
ATR (14)	0.07
RSI (14)	38.90
Beta	-1.69
Rel Volume	1.04
Avg Volume	155.61K
Volume	72,451

Perf Week	2.51%
Perf Month	-7.68%
Perf Quarter	-57.45%
Perf Half Y	-62.04%
Perf YTD	-68.13%
Perf Year	-87.62%
Perf 3Y	-92.09%
Perf 5Y	-99.44%
Perf 10Y	-100.00%
Recom	1.00
Target Price	11.00
Prev Close	0.89
Price	0.91
Change	3.11%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)